Friday, November 19, 2010

Eurosurveillance On Antimicrobial Resistance




# 5070




As antibiotic awareness week continues here in the US (see CDC: Get Smart About Antibiotics Week), and across Europe (European Antibiotic Awareness Day), public health agencies are working to focus public and professional attention on the growing problem of antimicrobial resistance.


This week I’ve paid extra attention to this issue in this blog with several extended reports, including:


ECDC/EMEA: Joint Report On Resistant Bacteria
Carbapenemases Rising


And of course, every week is antibiotic awareness week on Maryn McKenna’s Superbug blog


Carbapenemases are a diverse (and growing) group of bacteria that have developed an enzyme that disrupt the antimicrobial actions of the  Carbapenem class of antibiotics – often drugs of last resort when dealing with serious bacterial infections.


This week’s edition of Eurosurveillance is focused almost entirely on the issue of antibiotic resistance, and while some of these articles are of interest primarily to clinicians and researchers, I wanted to pass the links on to my readers.


If you read nothing else, the editorial - Antimicrobial resistance 2010: global attention on carbapenemase-producing bacteria provides an excellent overview of the problem, and is well worth reading. 




Eurosurveillance, Volume 15, Issue 46, 18 November 2010

Table of Contents


Antimicrobial resistance 2010: global attention on carbapenemase-producing bacteria

by ECDC Antimicrobial Resistance and Healthcare-Associated Infections Programme

Rapid communications

Possible importation and subsequent cross-transmission of OXA-48-producing Klebsiella pneumoniae, France, 2010

by D Decre, G Birgand, D Geneste, E Maury, JC Petit, F Barbut, G Arlet

Research articles

New Delhi metallo-beta-lactamase 1–producing Enterobacteriaceae: emergence and response in Europe

by MJ Struelens, DL Monnet, AP Magiorakos, F Santos O’Connor, J Giesecke, the European NDM-1 Survey Participants

Prevalence of meticillin-resistant Staphylococcus aureus amongst professional meat handlers in the Netherlands, March–July 2008

by R de Jonge, JE Verdier, AH Havelaar


Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts

by H Grundmann, DM Livermore, CG Giske, R Canton, GM Rossolini, J Campos, A Vatopoulos, M Gniadkowski, A Toth, Y Pfeifer, V Jarlier, Y Carmeli, the CNSE Working Group

Surveillance and outbreak reports

Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003–2004

by N Kassis-Chikhani, F Saliba, A Carbonne, S Neuville, D Decre, C Sengelin, C Guerin, N Gastiaburu, A Lavigne-Kriaa, C Boutelier, G Arlet, D Samuel, D Castaing, E Dussaix, V Jarlier

Appropriateness of antimicrobial therapy: a multicentre prevalence survey in the Netherlands, 2008–2009

by I Willemsen, T van der Kooij, B van Benthem, J Wille, J Kluytmans

No comments: